Effect of short- and long-acting β2-adrenoceptor agonists on pulmonary β2-adrenoceptor expression in human lung

European Journal of Pharmacology

Volumn 318, Issue 1, 1996, Pages 123-129

  Nishikawa, Masanori ^a,b   Mak, Judith C W ^a   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

2 Adrenoceptor; Down regulation; Formoterol; Lung, human; Salbutamol; Salmeterol

Indexed keywords

5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYANOPINDOLOL I 125; FORMOTEROL; ISOPRENALINE; MESSENGER RNA; SALBUTAMOL; SALMETEROL;

ADULT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LUNG; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; BINDING SITES; BINDING, COMPETITIVE; BLOTTING, NORTHERN; DOWN-REGULATION; ETHANOLAMINES; HUMANS; ISOPROTERENOL; LUNG; MALE; RECEPTORS, ADRENERGIC, BETA-2; RNA, MESSENGER;

EID: 0030604281     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00769-8     Document Type: Article

References (31)

1. Aarons, R.D., A.S. Nies, J.G. Gerber and P.B. Molinoff, 1983, Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists, J. Pharmacol. Exp. Ther. 224, 1.
2. Barnes, P.J., 1995, Beta-adrenergic receptors and their regulation, Am. J. Respir. Crit. Care Med. 152, 838.
3. 2-adrenoceptor agonists in asthma, Trends Pharmacol. Sci. 13, 20.
4. British Thoracic Society, 1993, Guidelines on the management of asthma, Thorax 48 (Suppl.), S1.
5. 2-adrenoceptors. Accelerated restoration of β-adrenoceptor responsiveness by predonisone and ketotifen, J. Clin. Invest. 76, 1096.
6. Carstairs, J.R., A.J. Nimmo and P.J. Barnes, 1985, Autoradiographic visualization of β-adrenoceptors in human lung, Am. Rev. Respir. Dis. 132, 541.
7. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma, New Engl. J. Med. 327, 1198.
8. Chromczynski, P. and N. Sacci, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162, 156.
9. Cockcroft, D., C.P. McParrand, S.A. Britto, V.A. Swystun and C. Rutherford, 1993, Regular inhaled salbutamol and airway responsiveness to allergen, Lancet 342, 833.
10. 2-adrenoceptors, Eur. J. Pharmacol. 130, 137.
11. 2-adrenoceptors in guinea pig and human lung, Prostgrad. Med. J. 57 (Suppl. 1), 77.
12. Galant, S.P., L. Duriseti, S. Underwood and P.A. Insel, 1978, Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy, New Engl. J. Med. 229, 933.
13. Hadcock, J.R. and C.C. Malbon, 1988, Down-regulation of β-adrenergic receptors: agonist-induced reduction in receptor mRNA levels, Proc. Natl. Acad. Sci. USA 85, 5021.
14. 2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography, Eur. J. Pharmacol. Mol. Pharmacol. 206, 133.
15. Hataoka, I., M. Okayama, M. Sugi, H. Inoue, T. Takishima and K. Shirato, 1993, Decrease in beta-adrenergic receptors of lymphocytes in spontaneously occurring acute asthma, Chest 104, 508.
16. 2-Adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients, Chest 98, 376.
17. Kent, R.S., A. De Lean and R.J. Lefkowitz, 1980, A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data, Mol. Pharmacol. 17, 14.
18. Kerrebijin, K.F., 1991, Beta agonists, in: Asthma, Its Pathology and Treatment, eds. M.A. Kaliner, P.J. Barnes and C.G.A. Persson (Marcel Dekker, New York, NY) p. 526.
19. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265.
20. 2-adrenergic receptor transcription in human lung, Am. J. Physiol. 268, L41.
21. 2-adrenergic receptors in vivo, J. Clin. Invest. 96, 99.
22. Manolitsas, N.D., J. Wang, J.L. Devalia, C.J. Trigg, A.E. McAulay and R.J. Davies, 1995, Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma, Am. J. Respir. Crit. Care Med. 151, 1925.
23. Meurs, H., H.F. Kauffman, G.H. Koëter, A. Timmermans and K. De Vries, 1987, Regulation of the beta-receptor-adenylate cyclase system in lymphocytes of allergic patients with asthma: possible role for protein kinase C in allergen-induced nonspecific refractoriness of adenylate cyclas, J. Allergy Clin. Immunol. 80, 326.
24. Nelson, H.S., 1995, β-Adrenergic bronchodilators, New Engl. J. Med. 333, 499.
25. 2-adrenoceptor messenger RNA with prolonged in vivo infusion of isoprenaline, Eur. J. Pharmacol. Mol. Pharmacol. 247, 131.
26. Nishikawa, M., J.C.W. Mak, H. Shirasaki, S.E. Harding and P.J. Barnes, 1994, Long-term exposure to norepinephrine results in down-regulation and reduced mRNA expression of pulmonary β-adrenergic receptors in guinea pigs, Am. J. Respir. Cell Mol. Biol. 10, 91.
27. 2-agonists in asthma, New Engl. J. Med. 327, 1204.
28. Sears, M.R., D.R. Taylor, C.G. Print, D.C. Lake, Q. Li, E.M. Flannery, D.M. Yates, M.K. Lucas and G.P. Herbison, 1990, Regular inhaled β-agonist treatment in bronchial asthma, Lancet 336, 1391.
29. Tattersfield, A.E., 1985, Tolerance to beta-agonists, Clin. Respir. Physiol. 21, 1.
30. Taylor, D.R., M.R. Sears, G.P. Herbison, E.M. Flannery, C.G. Print, D.C. Lake, D.M. Yates, M.K. Lucas and Q. Li, 1993, Regular inhaled β agonist in asthma: effects on exacerbations and lung function, Thorax 48, 134.
31. Yates, D.H., M. Worsdell, H. Sussman, M. Shaw, P.J. Barnes and K.F. Chung, 1995, Regular formoterol treatment in mild asthma: effect on bronchial reactivity during and after treatment (abstract), Am. J. Respir. Crit. Care Med. 151, A272.